Prognostic Factors of Hepatosplenic T-cell Lymphoma
Mariko Yabe(Memorial Sloan Kettering Cancer Center), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Keyur P. Patel(The University of Texas MD Anderson Cancer Center), Weina Chen(Army Medical University), Ken H. Young(Duke Medical Center), Govind Bhagat(Columbia University Irving Medical Center), Shimin Hu(The University of Texas MD Anderson Cancer Center), M. James You, Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Jeffrey L. Jorgensen(The University of Texas MD Anderson Cancer Center), Yago Nieto(The University of Texas MD Anderson Cancer Center), Yasuhiro Oki(Unknown), Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Daniela Hoehn(Columbia University Irving Medical Center), Sergej Konoplev(The University of Texas MD Anderson Cancer Center), Mark J. Routbort(The University of Texas MD Anderson Cancer Center), Guilin Tang(The University of Texas MD Anderson Cancer Center), Rajyalakshmi Luthra, Michelle A. Fanale(Pfizer (United States)), Sa A. Wang(Beijing Institute of Technology), Shaoying Li(Third Affiliated Hospital of Guangzhou Medical University), L. Jeffrey Medeiros(Delaware Division of Libraries), Denái R. Milton(Cancer Research And Biostatistics), Francisco Vega(The University of Texas MD Anderson Cancer Center)
Cited by 82
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k